Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › RNAi agents for inhibiting expression of DUX4, compositions thereof, and methods of use

RNAi agents for inhibiting expression of DUX4, compositions thereof, and methods of use

US Patent 11845937 · Granted Dec 19, 2023

Estimated economic value: $45,038,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

RNAi agents for inhibiting expression of inhibin subunit beta E (INHBE), pharmac2025
Compositions and methods comprising histidyl-tRNA synthetase splice variants hav2025
RNAi agents for inhibiting expression of receptor for advanced glycation end-pro2025
RNAi agents for inhibiting expression of receptor for advanced glycation end-pro2025
5′-cyclo-phosphonate modified nucleotides2025
RNAi agents for inhibiting expression of activin receptor-like kinase 7 (ALK7), 2025
RNAi agents for inhibiting expression of complement factor B (CFB), pharmaceutic2025
RNAi agents for inhibiting expression of complement factor B (CFB), pharmaceutic2025
RNAi agents for inhibiting expression of complement factor B (CFB), pharmaceutic2025
RNAi agents for inhibiting expression of complement factor B (CFB), pharmaceutic2025
RNAi agents for inhibiting expression of mucin 5AC (MUC5AC), compositions thereo2025
RNAi agents for inhibiting expression of mucin 5AC (MUC5AC), compositions thereo2025